Company · CIK 0001162194 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
STANDARD BIOTOOLS INC. · LAB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 FForm 4 → | Aug 24, 5:06 pm EDT | Sean MackaySVP & Chief Business Officer | 25,729 | $0.672 | $17,290 | 1,480,823 | — | |
| Aug 20, 2026 FForm 4 → | Aug 24, 5:05 pm EDT | Hanjoon Alex KimChief Financial Officer | 28,195 | $0.672 | $18,947 | 2,534,859 | — | |
| Aug 20, 2026 FForm 4 → | Aug 24, 5:04 pm EDT | Michael EgholmPresident & CEO, Director | 97,627 | $0.672 | $65,605 | 6,137,704 | — | |
| Aug 3, 2026 FForm 4 → | Aug 4, 6:01 pm EDT | Michael EgholmPresident & CEO, Director | 362,625 | $0.868 | $314,759 | 6,235,331 | — | |
| Jul 23, 2026 FForm 4 → | Jul 27, 7:28 pm EDT | Hanjoon Alex KimChief Financial Officer | 202,476 | $0.895 | $181,216 | 2,563,054 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.